Investor Relations

Nancy C. Andrews, M.D., Ph.D. has more than 30 years of experience overseeing prominent medical research and healthcare organizations. Her career contributions as a physician, scientist, educator, and administrator have culminated in leadership roles at three of the premier medical research institutions in the United States. Dr. Andrews was appointed as Executive Vice President and Chief Scientific Officer at Boston Children's Hospital in December 2021. Previously, she was Professor of Pediatrics, Pharmacology, and Cancer Biology, Dean Emerita of the School of Medicine and Vice Chancellor Emerita for Academic Affairs, Duke University. Prior to joining Duke University in 2007, Dr. Andrews served as Dean for Basic Sciences and Graduate Studies and the George Richards Minot Professor of Pediatrics at the Harvard Medical School, as well as Director of the Harvard-MIT M.D.-Ph.D. Program. She was also a biomedical research investigator at the Howard Hughes Medical Institute. Dr. Andrews currently serves on the Board of Directors of Novartis International AG, and is also on the Executive Committee of the MIT Corporation; Chair of the Board of Directors of the American Academy of Arts and Sciences; and a member of the Scientific Advisory Board of Dyne Therapeutics. Dr. Andrews received an M.D. degree from Harvard Medical School, a Ph.D. degree in Biology from Massachusetts Institute of Technology, and B.S. and M.S. degrees in Molecular Biophysics and Biochemistry from Yale University. Dr. Andrews has been a director since February 2020.